Top Industry Leaders in the Vascular Patches Market
Getinge AB (Sweden) Increased its high-quality vascular graft production in May 2022, responding to the high demand and strengthening its market position.
Aziyo Biologics Received USD 14 million in public equity (PIPE) financing in December 2021, supporting the company's growth opportunities in regenerative medicine, which could potentially impact the development of biocompatible vascular patches.
Terumo Aortic (Japan) Announced the start of PANTHER, a global surgical transplant research project in September 2021, focusing on their entire line of knitted and woven patches, demonstrating commitment to research and development in the field.
LeMaitre Vascular (US) Acquired the business and assets of Artegraft, Inc. in July 2020, strengthening their portfolio of biologic vascular patches and expanding their product offerings.
B. Braun SE (Germany) Launched their PROPATCH® PLUS ePTFE Cardiovascular Patch in November 2022, featuring a unique surface modification for enhanced tissue integration and potentially improving surgical outcomes.
List of Vascular Patches Key Companies in the Market
-
Terumo Corporation (Japan)
-
C. R. Bard Inc. (US)
-
B. Braun Melsungen AG (Germany)
-
LeMaitre Vascular Inc. (US)
-
Maquet (Germany)
-
W. L. Gore & Associates Inc. (US)
-
Admedus (Australia)
-
CryoLife Inc. (US)
-
Labcor Laboratórios Ltd. (Brazil)
-
Baxter International Inc. (US)